SDC1 and prostate cancer: Appl1, Sortilin and Syndecan-1 are biomarkers within the endosome-lysosome system, and immunohistochemistry (IHC) labelling of these proteins may enable improved visualisation of the complex pathologies underlying prostate cancer [20].